Concepedia

Marie Villedieu

MV

Statistics

Publications

11

Citations

649

H-Index

11

Active since

2006

Affiliations

Centre François Baclesse(Current)

Inserm

Cancers et Préventions

Université Claude Bernard Lyon 1

Centre Léon Bérard

Marie Villedieu is an author at Centre François Baclesse specializing in cancer biology, tumor biology, and medicine.

ORCID

Top concepts

Publications per year

2006–2023

11

Publications

11

Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro.

Xiao Dong Zhang, E. Deslandes, Marie Villedieu et al. · PubMed · 2006 · 126 citations

Bcl‐<scp>X<sub>L</sub></scp> and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis

Émilie Brotin, Matthieu Meryet‐Figuière, Karin Simonin et al. · International Journal of Cancer · 2009 · 110 citations

, , +18

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

Paul Vilquin, Caterina F. Donini, Marie Villedieu et al. · Breast Cancer Research · 2015 · 79 citations · Full text

Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment

Marie Villedieu, E. Deslandes, Marilyne Duval et al. · Gynecologic Oncology · 2006 · 53 citations

, , +8

PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced

Abdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier et al. · Cancer Letters · 2014 · 53 citations · Full text

, , +12

1–5 of 11